Arcellx price target raised to $115 from $91 at Piper Sandler
Piper Sandler raised the firm’s price target on Arcellx (ACLX) to $115 from $91 and keeps an Overweight rating on the shares following Q3 ...
Is Arcellx (ACLX) Outperforming Other Medical Stocks This Year?
Based on the latest available data, ACLX has gained about 78.7% so far this year. Meanwhile, the Medical sector has returned an average of 4% on a year-to-date basis. This means that Arcellx, Inc. is ...
Arcellx Inc’s Promising Clinical Data and Safety Profile Drive Buy Rating
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on ACLX stock, giving a Buy rating on November 6. Tyler Van Buren has ...
Arcellx (NASDAQ:ACLX) Given New $106.00 Price Target at Morgan Stanley
Arcellx (NASDAQ:ACLX – Get Free Report) had its price target increased by Morgan Stanley from $81.00 to $106.00 in a research ...